Z-WEHD-FMK: Irreversible Caspase-5 Inhibitor for Inflammation and Apoptosis Research

Executive Summary: Z-WEHD-FMK (CAS 210345-00-9) is a potent, cell-permeable, irreversible inhibitor primarily targeting inflammatory caspases-1, -4, and -5, which are central to pyroptosis and inflammatory signaling (Padia et al., 2025). It blocks caspase-mediated cleavage events, such as golgin-84 processing during Chlamydia infection, thereby restricting bacterial proliferation (ITF2357.com). Z-WEHD-FMK is insoluble in water but highly soluble in DMSO and ethanol under ultrasonic assistance, with optimal storage at -20°C (APExBIO product page). Standard protocols utilize 80 μM Z-WEHD-FMK for 9 hours in HeLa cell models to achieve near-complete inhibition of golgin-84 cleavage. Its application has been instrumental in dissecting caspase signaling pathways in both cell death and microbial pathogenesis (z-wehd-fmk.com).

Biological Rationale

Inflammatory caspases, including caspase-1, -4, and -5, are essential mediators of pyroptosis, a form of pro-inflammatory programmed cell death. Caspase-1 is activated via canonical inflammasomes (e.g., NLRP3), resulting in cleavage of gasdermin D and subsequent cell lysis (Padia et al., 2025). Non-canonical inflammasome signaling involves direct activation of caspase-4/5 by cytosolic lipopolysaccharide (LPS), further broadening the scope of innate immune responses. Dysregulated caspase-1 activity is implicated in tumorigenesis, as observed in non-small cell lung carcinoma (NSCLC), where its suppression prevents pyroptosis and supports tumor growth. In infectious disease models, such as Chlamydia trachomatis infection, caspase-1-dependent cleavage of host proteins facilitates pathogen replication (ITF2357.com).

Mechanism of Action of Z-WEHD-FMK

Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) is a synthetic, irreversible inhibitor that covalently modifies the active cysteine residue in the catalytic site of caspase proteases. Its cell-permeable structure allows efficient intracellular delivery, selectively targeting caspase-1, -4, and -5. Upon binding, Z-WEHD-FMK prevents substrate cleavage, blocking downstream signaling, including the processing of pro-inflammatory cytokines (e.g., IL-1β) and pyroptotic mediators (e.g., gasdermin D). The irreversible nature of inhibition ensures persistent blockade during experimental time frames, facilitating analysis of caspase-dependent mechanisms in inflammation, apoptosis, and infection (APExBIO).

Evidence & Benchmarks

• Z-WEHD-FMK irreversibly inhibits caspase-1, -4, and -5 proteolytic activity in vitro and in mammalian cell lines (Padia et al., 2025).
• Treatment of Chlamydia trachomatis-infected HeLa cells with 80 μM Z-WEHD-FMK for 9 hours blocks golgin-84 cleavage and reduces infectious bacterial yield by ~2 logs (ITF2357.com).
• Z-WEHD-FMK is insoluble in water but achieves ≥46.33 mg/mL solubility in DMSO and ≥26.32 mg/mL in ethanol with ultrasonic assistance (APExBIO).
• Inhibition of caspase-1 with Z-WEHD-FMK suppresses pyroptosis in HOXC8-knockdown NSCLC cells, confirming caspase-1’s role in cell death and tumorigenesis (Padia et al., 2025).
• Optimized storage at -20°C preserves compound integrity, but long-term storage of working solutions is not recommended (APExBIO).

Applications, Limits & Misconceptions

Z-WEHD-FMK is critical for:

• Dissecting caspase-mediated signaling in inflammation research and apoptosis assays.
• Investigating microbial pathogenesis, particularly Chlamydia-induced Golgi fragmentation and lipid trafficking alterations (ITF2357.com).
• Validating the role of caspase-1 and related enzymes in cancer models, as demonstrated in studies of HOXC8 regulation and NSCLC pyroptosis (Padia et al., 2025).
• Supporting drug discovery workflows for targeting caspase signaling pathways.

For extended discussion on practical assay design with Z-WEHD-FMK (A1924), see this scenario-driven guidance, which offers insights on reproducibility and protocol optimization. This article expands on those recommendations by incorporating new clinical research on caspase-1 in tumorigenesis.

Common Pitfalls or Misconceptions

• Non-selectivity for non-caspase proteases: Z-WEHD-FMK does not inhibit serine or metalloproteases; its activity is restricted to caspase family cysteine proteases (APExBIO).
• Water solubility: The inhibitor is insoluble in aqueous buffers; DMSO or ethanol (with sonication) are required for stock preparation.
• Long-term solution stability: Working solutions degrade over time; only prepare immediately before use.
• Irreversibility: Z-WEHD-FMK cannot be washed out to reverse inhibition; irreversible binding necessitates careful timing and dosing.
• Applicability to all cell types: While widely applicable, permeability and activity should be validated in specific model systems (see further discussion).

Compared to previous overviews (z-wehd-fmk.com), this article clarifies the inhibitor's mechanistic boundaries and highlights recent cancer research.

Workflow Integration & Parameters

Standard experimental protocols for Z-WEHD-FMK (A1924) involve preparing a DMSO stock (≥46.33 mg/mL) under ultrasonic conditions and storing at -20°C (APExBIO). For cell-based assays:

• HeLa cells infected with C. trachomatis are treated with 80 μM Z-WEHD-FMK for 9 hours at 37°C to block golgin-84 cleavage (ITF2357.com).
• Pyroptosis studies in NSCLC models utilize caspase-1 inhibition to confirm dependency of cell death upon HOXC8 knockdown (Padia et al., 2025).
• Compound addition should be the final step after infection or transfection, with rapid mixing to ensure even distribution.
• Control experiments require vehicle-only (DMSO/ethanol) conditions to account for solvent effects.

For additional troubleshooting and workflow optimization, see the detailed stepwise guide at ss-amyloid-1-11.com; this article provides updated recommendations reflecting recent advances in caspase biology.

Conclusion & Outlook

Z-WEHD-FMK, provided by APExBIO, represents a gold-standard tool for irreversible inhibition of caspase-1, -4, and -5. Its robust performance in cell-based models has advanced research in inflammation, apoptosis, and microbial pathogenesis. Recent discoveries in cancer biology further underscore its value in mechanistic studies of pyroptosis and tumorigenesis. With careful attention to solubility, dosing, and irreversibility, Z-WEHD-FMK (A1924) will remain a critical reagent for dissecting caspase signaling pathways.

For product specifications and ordering, see the official APExBIO page for Z-WEHD-FMK.